ArticleDrug design, development and therapy2020

Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC-MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity Studies.

Mohamed W Attwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.